20th Annual Scientific Symposium Of The Cardiovascular Research Foundation Oct. 12-17, Washington, D.C.

Main Category: Cardiovascular / Cardiology
Also Included In: Medical Devices / Diagnostics;  Conferences;  Heart Disease
Article Date: 30 Sep 2008 - 2:00 PDT

email to a friend   printer friendly   opinions  

Data from ground-breaking scientific trials of new interventional techniques and devices will be released at TCT 2008 - Transcatheter Cardiovascular Therapeutics - the global annual scientific symposium of the Cardiovascular Research Foundation. Researchers will present a variety of new data that promises to advance the field of interventional cardiology. Featured trials will focus on the safety and efficacy of new devices, including drug-eluting stents and other leading edge technologies, as well as comparisons of minimally invasive therapies to either medical treatment or surgery.

TUESDAY, OCTOBER 14, 9:30 A.M.

COOL RCN: A Prospective Randomized Trial Examining the Safety and Efficacy of Systemic Hypothermia for the Prevention of Radiocontrast Nephropathy ISAR-Left Main: A Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Disease

FAME: A Prospective Randomized Trial of Fractional Flow Reserve Guided Stenting in Patients with Multivessel Coronary Artery Disease ODESSA: A Prospective Randomized Study Using Optical Coherence Tomography to Evaluate Strut Coverage of Sirolimus-Eluting, Paclitaxel-Eluting, and Zotarolimus-Eluting Coronary Stents

DECREASE: A Prospective Registry Examining the Safety and Efficacy of Triple Antiplatelet Therapy After Drug-Eluting Stent Implantation

SOS: A Prospective Randomized Trial of Paclitaxel-Eluting Stents vs. Bare-Metal Stents in Saphenous Vein Graft Lesions

ENDEAVOR IV: Two-Year Follow-Up from a Prospective Randomized Trial Comparing a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

WEDNESDAY, OCTOBER 15, 9:00 A.M.

ZEST-AMI: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents, Sirolimus-Eluting Stents, and Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction

PREPARE: A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

ARNO: A Prospective Randomized Trial Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients Undergoing Elective Percutaneous Coronary Intervention

NAPLES: A Prospective Randomized Trial Comparison of Bivalirudin and Unfractionated Heparin Plus Tirofiban in Patients with Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention

PROBI VIRI: A Prospective Randomized Trial of an Extended Bivalirudin Infusion in Patients Undergoing Percutaneous Coronary Intervention

ASSIST: A Prospective Randomized Trial Evaluating Early Eptifibatide Administration in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Thienopyridine Loading

FATA: A Prospective Randomized Trial of Tirofiban and Abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

HORIZONS-AMI: A Prospective Randomized Trial of Paclitaxel-Eluting Stents vs. Bare-Metal Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction

HORIZONS-AMI: A Prospective Randomized Trial of Bivalirudin vs. Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Segment Elevation Myocardial Infarction: Long-Term Follow-Up and Interaction with Stent Type

THURSDAY, OCTOBER 16, 9:00 A.M.

SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

BBC ONE: A Prospective Randomized Comparison of a Single Drug-Eluting Stent Provisional Strategy vs. Routine Dual Drug-Eluting Stents for Coronary Bifurcation Lesions

ISAR-TEST-2: A Prospective Randomized Trial Comparing Polymer-Free Rapamycin-Eluting and Probucol-Eluting Stents, Polymer-Based Sirolimus-Eluting Stents, and Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease

ESTROFA-2: A Large-Scale Registry Examining the Rates of Stent Thrombosis After Implantation of Zotarolimus-Eluting and Everolimus-Eluting Stents in Patients with Coronary Artery Disease

EMPIRE: A Multicenter Registry Evaluating Neuroprotection During Carotid Stenting with a Novel Flow Reversal System

EPIC: A Multicenter Registry Evaluating Neuroprotection During Carotid Stenting with a Novel Distal Protection Device First in Human Report: Initial Experience with a Stentless and Retrievable Percutaneous Aortic Valve Prosthesis

DIVERGE: A Large-Scale Registry Evaluating a Novel Self-Expanding Drug-Eluting Bifurcation Stent: Clinical, Angiographic, and IVUS Results

Western Denmark Heart Registry: A Large-Scale Registry Examining the Safety and Efficacy of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

In addition, research presented at TCT will showcase breaking data in other areas of interventional cardiology:

• Drug therapies that may reduce plaque
  
  
• The differences in the ways that men and women with similar symptoms are treated by physicians
  
  
• New types of stents, including bioabsorbable devices
  
  
• New ways of detecting and reducing plaque, including vulnerable plaque that can cause sudden heart attack and death

WHERE:

Walter E. Washington Convention Center; Washington, DC

###

Click here to view the final program.

Source: Judy Romero
Cardiovascular Research Foundation

• Additional
• References
• Citations